Effect of xylitol and other carbon sources on Streptococcus pneumoniae biofilm formation and gene expression in vitro

被引:30
作者
Kurola, Paula [1 ]
Tapiainen, Terhi [2 ]
Sevander, Jenny [2 ]
Kaijalainen, Tarja [1 ]
Leinonen, Maija [1 ]
Uhari, Matti [2 ]
Saukkoriipi, Annika [1 ]
机构
[1] Natl Inst Hlth & Welf, Oulu, Finland
[2] Univ Oulu, Dept Pediat, Oulu, Finland
关键词
Biofilm; gene expression; pneumococcus; xylitol; COLONIZATION; VARIANTS; FRUCTOSE; MUTANS; GROWTH; DNA; GUM;
D O I
10.1111/j.1600-0463.2010.02703.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Xylitol inhibits the growth of Streptococcus pneumoniae. In clinical trials, xylitol decreased the occurrence of acute otitis media in day-care children, but did not decrease nasopharyngeal carriage of pneumococci. We hypothesized that xylitol inhibits biofilm formation of pneumococci, and measured biofilm formation and gene expression levels of the capsule gene cpsB and two other genes: autolysin encoding gene lytA and competence gene comA in different growth media in vitro. Twenty pneumococcal isolates were grown on polystyrene plates for 18 h in test media containing 0.5% xylitol, 0.5% glucose, 0.5% xylitol and 0.5% glucose, 0.5% fructose, 0.5% xylitol and 0.5% fructose or brain heart infusion (BHI) medium supplemented with 10% horse serum. Gene expression levels were measured after 5 h of growth using a relative quantification method with calibrator normalization. Exposure to xylitol lowered OD values, which were used as an indication of biofilm, compared with BHI medium, but when the medium was supplemented with glucose or fructose, biofilm formation was enhanced and the inhibitory effect of xylitol on biofilm formation was not observed. Xylitol also lowered lytA expression levels. Changes in biofilm formation in response to different sugar compounds may partly explain the efficacy of xylitol to prevent acute otitis media in previous clinical trials.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 29 条
[1]   Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms [J].
Allegrucci, Magee ;
Sauer, Karin .
JOURNAL OF BACTERIOLOGY, 2007, 189 (05) :2030-2038
[2]   In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol [J].
Ammons, Mary Cloud B. ;
Ward, Loren S. ;
Fisher, Steve T. ;
Wolcott, Randall D. ;
James, Garth A. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (03) :230-236
[3]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[4]   Biofilms: Survival mechanisms of clinically relevant microorganisms [J].
Donlan, RM ;
Costerton, JW .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (02) :167-+
[5]   Streptococcus parasanguis fimbria-associated adhesin Fap1 is required for biofilm formation [J].
Froeliger, EH ;
Fives-Taylor, P .
INFECTION AND IMMUNITY, 2001, 69 (04) :2512-2519
[6]   Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates [J].
Hall-Stoodley, Luanne ;
Nistico, Laura ;
Sambanthamoorthy, Karthik ;
Dice, Bethany ;
Nguyen, Duc ;
Mershon, William J. ;
Johnson, Candice ;
Hu, Fen Ze ;
Stoodley, Paul ;
Ehrlich, Garth D. ;
Post, J. Christopher .
BMC MICROBIOLOGY, 2008, 8 (1)
[7]   Antiadhesive effects of xylitol on otopathogenic bacteria [J].
Kontiokari, T ;
Uhari, M ;
Koskela, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) :563-565
[8]  
Kontiokari T, 1999, FEMS MICROBIOL LETT, V178, P313, DOI 10.1016/S0378-1097(99)00376-6
[9]   Xylitol and capsular gene expression in Streptococcus pneumoniae [J].
Kurola, Paula ;
Tapiainen, Terhi ;
Kaijalainen, Tarja ;
Uhari, Matti ;
Saukkoriipi, Annika .
JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (11) :1470-1473
[10]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408